CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-04 | Quart Barry D Chief Executive Officer | Gift | −600 | 0 | ||
| 2016-11-04 | Quart Barry D Chief Executive Officer | Gift | +600 | 92,509 | ||
| 2016-10-31 | Drazba Brian G. VP, Finance & CFO | Other acquisition | +538 | $12.62 | $7K | 3,798 |
| 2016-10-07 | Johnson Craig A Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2016-08-10 | Rosen Robert President & CCO | Exercise or conversion | +100,000 | $7.20 | $720K | 102,640 |
| 2016-08-10 | Rosen Robert President & CCO | Sale | −87,600 | $23.21 | $2.0M | 15,040 |
| 2016-08-10 | Rosen Robert President & CCO | Sale | −12,400 | $23.89 | $296K | 2,640 |
| 2016-08-10 | Rosen Robert President & CCO | Exercise or conversion · Employee Stock Option (Right to Buy) | −100,000 | 825,000 | ||
| 2016-07-19 | Quart Barry D Chief Executive Officer | Exercise or conversion | +4,630 | $7.20 | $33K | 66,309 |
| 2016-07-19 | Quart Barry D Chief Executive Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −4,630 | 930,277 | ||
| 2016-06-22 | Johnson Craig A Director | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2016-06-22 | Christian Waage Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-06-22 | Christian Waage Director | Grant or award · Stock Option (Right to Buy) | +1,500 | 1,500 | ||
| 2016-06-16 | TANG KEVIN C Director | Exercise or conversion | +1,250,000 | $3.60 | $4.5M | 6,117,530 |
| 2016-06-16 | TANG KEVIN C Director | Shares withheld for taxes | −243,639 | $18.47 | $4.5M | 5,873,891 |
| 2016-06-16 | TANG KEVIN C Director | Exercise or conversion · Warrant (Right to Buy) | −1,250,000 | 0 | ||
| 2016-04-29 | Drazba Brian G. VP, Finance & CFO | Other acquisition | +577 | $18.22 | $11K | 3,260 |
| 2016-04-29 | Quart Barry D Chief Executive Officer | Other acquisition | +837 | $18.22 | $15K | 61,679 |
| 2016-04-21 | Rosen Robert President | Exercise or conversion | +19,662 | $7.20 | $142K | 22,302 |
| 2016-04-21 | Rosen Robert President | Sale | −19,662 | $22.15 | $435K | 2,640 |
Page 35 of 38 · 746 trades